US Map / Colorado
State CO

Clinical Trials in Colorado

Recruiting clinical trials with at least one study location in Colorado. Data updated daily from ClinicalTrials.gov.

Total Trials
130
Recruiting Now
130
← Back to US Map
Top Conditions in Colorado
Non-small Cell Lung Cancer (3)Breast Cancer (3)Rheumatoid Arthritis (3)Multiple Myeloma (3)Asthma (3)Exercise (3)COPD (3)Carcinoma, Non-Small-Cell Lung (2)Solid Tumors (2)Spinal Cord Injuries (2)Bipolar I Disorder (2)Coronary Artery Disease (2)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 130 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 130. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Non-small Cell Lung Cancer, Breast Cancer, Rheumatoid Arthritis, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT06690801 N/A
Recruiting
Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Synd...
Condition
Acute Respiratory Distress Syndrome
Enrollment
1,260 pts
Location
United States
Sponsor
Children's Hospital Los Angele
View Trial →
NCT06858319 Phase 3
Recruiting
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Condition
Kidney Diseases
Enrollment
220 pts
Location
United States, Argentina, Malaysia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06239831 N/A
Recruiting
Postoperative Respiratory and Activity Monitoring
Condition
Hypoventilation
Enrollment
30 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06052267 Phase 3
Recruiting
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol ...
Condition
Asthma
Enrollment
2,700 pts
Location
United States, Argentina, Australia
Sponsor
Teva Branded Pharmaceutical Pr
View Trial →
NCT01193075 N/A
Recruiting
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT...
Condition
Charcot Marie Tooth Disease
Enrollment
5,000 pts
Location
United States, Australia, Canada
Sponsor
Michael Shy
View Trial →
NCT06496620 Phase 2
Recruiting
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Condition
COPD
Enrollment
171 pts
Location
United States, Australia, Canada
Sponsor
Uniquity One (UNI)
View Trial →
NCT05327114 Phase 2, Phase 3
Recruiting
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory De...
Condition
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Enrollment
201 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
View Trial →
NCT06134232 Phase 2
Recruiting
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + ...
Condition
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Enrollment
400 pts
Location
United States
Sponsor
Dendreon
View Trial →
NCT06544499 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participan...
Condition
Primary Immune Thrombocytopenia (ITP)
Enrollment
69 pts
Location
United States, Austria, Bulgaria
Sponsor
argenx
View Trial →
NCT06686771 Phase 3
Recruiting
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Condition
Non-small Cell Lung Cancer
Enrollment
320 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT07415044 Phase 2
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Condition
Ulcerative Colitis (UC)
Enrollment
1,431 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT06587126 N/A
Recruiting
Feasibility of Cough Monitoring in Children
Condition
Cystic Fibrosis in Children
Enrollment
40 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06670521 Phase 2
Recruiting
Corticosteroids for Post-Extubation Dysphagia
Condition
Dysphagia
Enrollment
80 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06500884 Phase 2
Recruiting
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Condition
Multiple Myeloma
Enrollment
210 pts
Location
United States, Brazil, Netherlands
Sponsor
Janssen Research & Development
View Trial →
NCT04176198 Phase 1, Phase 2
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Condition
Myelofibrosis
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
Sumitomo Pharma America, Inc.
View Trial →
NCT06636383 N/A
Recruiting
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
Condition
Glycogen Storage Disease Type Ia
Enrollment
140 pts
Location
United States, Brazil, Canada
Sponsor
Ultragenyx Pharmaceutical Inc
View Trial →
NCT06448754 Phase 2
Recruiting
Volrustomig Priming Regimens Exploratory Phase II Platform Study
Condition
Non-small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Canada, China
Sponsor
AstraZeneca
View Trial →
NCT05355701 Phase 1
Recruiting
A Study to Learn About the Study Medicine Called PF-07799933 in People With Adva...
Condition
Melanoma
Enrollment
267 pts
Location
United States, Canada, Israel
Sponsor
Pfizer
View Trial →
NCT07066657 Phase 1
Recruiting
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Condition
Locally Advanced or Metastatic Solid Tumors
Enrollment
405 pts
Location
United States, China
Sponsor
ArriVent BioPharma, Inc.
View Trial →
NCT07446595 N/A
Recruiting
BfedBwell INSPIRE Pilot
Condition
Cancer Survivorship
Enrollment
25 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT03877653 N/A
Recruiting
Freedom-1 Study for Chronic Knee Pain
Condition
Osteoarthritic Knee Pain
Enrollment
100 pts
Location
United States
Sponsor
Curonix LLC
View Trial →
NCT06070012 Phase 2
Recruiting
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanom...
Condition
Uveal Melanoma
Enrollment
44 pts
Location
United States
Sponsor
Diwakar Davar
View Trial →
NCT07028463 N/A
Recruiting
ALERT-ED: Awareness and Linkage to Resources for At-Risk Emergency Department Pa...
Condition
High Fall Risk
Enrollment
20,700 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT00061828 N/A
Recruiting
A Prospective Database of Infants With Cholestasis
Condition
Biliary Atresia
Enrollment
1,000 pts
Location
United States, Canada
Sponsor
Arbor Research Collaborative f
View Trial →
NCT06673407 N/A
Recruiting
Group Exposure Workshops for Socially Anxious Undergraduates
Condition
Social Anxiety Disorder
Enrollment
200 pts
Location
United States
Sponsor
University of Colorado, Boulde
View Trial →
Page 4 of 6 — 130 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology